e-learning
resources
Virtual 2021
05.09.2021
Developments in biomarkers and treatment strategies for chronic lung diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Community acquired pneumonia in COPD patients: ?linical features and peculiarities of nitric oxide metabolism
U. Farkhutdinov (Ufa (Republic of Bashkortostan), Russian Federation), E. Amirova (Ufa (Republic of Bashkortostan), Russian Federation), R. Farkhutdinov (Ufa (Republic of Bashkortostan), Russian Federation)
Source:
Virtual Congress 2021 – Developments in biomarkers and treatment strategies for chronic lung diseases
Session:
Developments in biomarkers and treatment strategies for chronic lung diseases
Session type:
E-poster
Number:
718
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
U. Farkhutdinov (Ufa (Republic of Bashkortostan), Russian Federation), E. Amirova (Ufa (Republic of Bashkortostan), Russian Federation), R. Farkhutdinov (Ufa (Republic of Bashkortostan), Russian Federation). Community acquired pneumonia in COPD patients: ?linical features and peculiarities of nitric oxide metabolism. 718
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Related content which might interest you:
The cycle of the nitric oxide metabolism in patients with COPD and chronic cerebrovascular diseases (CCVD)
Source: Annual Congress 2013 –The vulnerable patient and ageing cells
Year: 2013
Exhaled nitric oxide in diagnosis and management of respiratory diseases
Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases
Year: 2013
Nasal nitric oxide measurement and a score of key clinical features for the screening of primary ciliary dyskinesia in patients with non-cystic fibrosis bronchiectasis
Source: International Congress 2016 – Possible phenotypes of bronchiectasis and exacerbations
Year: 2016
Relationship betweeen exhaled nitric oxide and clinical pattern in Community-acquired pneumonia patients
Source: International Congress 2017 – Insight into the pathogenesis of emphysema and pneumonia
Year: 2017
Inflammatory patterns in asthmatic children based on the measurement of alveolar nitric oxide
Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules
Year: 2013
Relationship between age and online nasal nitric oxide measured using different techniques in children with suspected primary ciliary dyskinesia
Source: Annual Congress 2013 –Clinical physiology and functional imaging in health and disease
Year: 2013
Fractional exhaled nitric oxide in chronic obstructive pulmonary disease
Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease
Year: 2015
Nitric oxide in the COPD pathogenesis in patients with pulmonary tuberculosis
Source: International Congress 2019 – Oxidative stress, hypoxia and microbial exposure in the pathogenesis of pulmonary disease
Year: 2019
Features of production nitric oxide at patients with a bronchial asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 445s
Year: 2006
Role of fractional exhaled nitric oxide(FeNO) in obstructive airway diseases in Indian population
Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease
Year: 2015
Nitric oxide from alveolar origin in cirrhotic patients: relationship with pulmonary haemodynamics and potential implications
Source: Annual Congress 2008 - Pulmonary hypertension II
Year: 2008
Bronchial and alveolar nitric oxide levels in healthy volunteers and patients with severe asthma
Source: International Congress 2016 – Airway biomarkers
Year: 2016
The role of FeNO measurement in exploration of respiratory symptoms in children with no diagnosis of asthma
Source: International Congress 2015 – Paediatric epidemiology: pulmonary complications, bronchiolitis and asthma
Year: 2015
Assessment of small airways dysfunction with impulse oscillometry, multiple flow nitric oxide and spirometry in the Wessex severe asthma cohort study
Source: International Congress 2015 – Lung function: waiting to exhale...
Year: 2015
Alveolar nitric oxide and its role in asthma control assessment
Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules
Year: 2013
Correlation between cold airway hyperresponsiveness and the content of nitric oxide in the exhaled air in patients with bronchial asthma
Source: International Congress 2014 – Multidimensional analysis of respiratory problems
Year: 2014
Value of exhaled nitric oxide in the evaluation of disease activity in sarcoidosis patients
Source: Eur Respir J 2002; 20: Suppl. 38, 174s
Year: 2002
The experience of monitoring the exhaled nitric oxide (FeNO) during the anti-IgE-therapy (omalizumab) in children with uncontrolled severe asthma
Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease
Year: 2015
Relationship of exaled nitric oxide and pulmonary function tests in childhood asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 679s
Year: 2006
Prevalence and relationship of hypomagnesiemia with children bronchial asthma control
Source: International Congress 2016 – Paediatric asthma: lessons learned from studies with large sample sizes and multi-centre drug studies
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept